Cargando…

HGF/MET Axis Induces Tumor Secretion of Tenascin-C and Promotes Stromal Rewiring in Pancreatic Cancer

SIMPLE SUMMARY: It has been previously shown that activation of the MET receptor by its ligand, the hepatocyte growth factor (HGF), modulates the tumor-stroma cross-talk in models of pancreatic cancer. We now wish to cast light on the molecular mechanisms by which this ligand/receptor pair sustains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Modica, Chiara, Olivero, Martina, Zuppini, Francesca, Milan, Melissa, Basilico, Cristina, Vigna, Elisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305254/ https://www.ncbi.nlm.nih.gov/pubmed/34298732 http://dx.doi.org/10.3390/cancers13143519

Ejemplares similares

MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk
por: Modica, Chiara, et al.
Publicado: (2018)

Genetic Ablation of the MET Oncogene Defines a Crucial Role of the HGF/MET Axis in Cell-Autonomous Functions Driving Tumor Dissemination
por: Modica, Chiara, et al.
Publicado: (2023)

Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor
por: Desole, Claudia, et al.
Publicado: (2021)

A receptor-antibody hybrid hampering MET-driven metastatic spread
por: Modica, Chiara, et al.
Publicado: (2021)

Targeting HGF/c-MET Axis in Pancreatic Cancer
por: Pothula, Srinivasa P., et al.
Publicado: (2020)

Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody
por: Modica, Chiara, et al.
Publicado: (2020)

HGF/Met Axis in Heart Function and Cardioprotection
por: Gallo, Simona, et al.
Publicado: (2014)

Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer
por: Pothula, Srinivasa P., et al.
Publicado: (2017)

hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers
por: Martinelli, Ilaria, et al.
Publicado: (2022)

Correction: hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers
por: Martinelli, Ilaria, et al.
Publicado: (2022)

Targeting the HGF-cMET Axis in Hepatocellular Carcinoma
por: Venepalli, Neeta K., et al.
Publicado: (2013)

The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
por: Wang, Haiyu, et al.
Publicado: (2020)

Activated HGF-c-Met Axis in Head and Neck Cancer
por: Arnold, Levi, et al.
Publicado: (2017)

HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation
por: Spina, Anna, et al.
Publicado: (2015)

Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer
por: Miranda, Oshin, et al.
Publicado: (2018)

HGF/c-Met Axis: The Advanced Development in Digestive System Cancer
por: Shao, Zhiwei, et al.
Publicado: (2020)

The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance
por: Huang, Xing, et al.
Publicado: (2019)

Progress of antibody-based inhibitors of the HGF–cMET axis in cancer therapy
por: Kim, Ki-Hyun, et al.
Publicado: (2017)

Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement
por: Huang, Xing, et al.
Publicado: (2020)

Crosstalk Mechanisms Between HGF/c-Met Axis and ncRNAs in Malignancy
por: Liu, Xin, et al.
Publicado: (2020)

Monoclonal Antibodies against the MET/HGF Receptor and Its Ligand: Multitask Tools with Applications from Basic Research to Therapy
por: Prat, Maria, et al.
Publicado: (2014)

MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis
por: Liang, Hongge, et al.
Publicado: (2020)

The Interplay between HGF/c-met Axis and Nox4 in BRAF Mutated Melanoma
por: Beretti, Francesca, et al.
Publicado: (2021)

HGF/c-Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR/NGF axis
por: Qin, Tao, et al.
Publicado: (2022)

HGF-MET as a breast cancer biomarker
por: Liu, Shuying
Publicado: (2015)

HGF/c-MET Signaling in Melanocytes and Melanoma
por: Czyz, Malgorzata
Publicado: (2018)

HGF–Met Pathway in Regeneration and Drug Discovery
por: Matsumoto, Kunio, et al.
Publicado: (2014)

Physiological Signaling and Structure of the HGF Receptor MET
por: Baldanzi, Gianluca, et al.
Publicado: (2014)

HGF/MET Signaling in Malignant Brain Tumors
por: Mulcahy, Elizabeth Qian Xu, et al.
Publicado: (2020)

HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancer
por: Mariani, Marisa, et al.
Publicado: (2014)

Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk
por: Barzaman, Khadijeh, et al.
Publicado: (2022)

Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion
por: Cao, Hui-Hui, et al.
Publicado: (2015)

Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours
por: Martin, Valentina, et al.
Publicado: (2019)

The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?
por: Boissinot, Marjorie, et al.
Publicado: (2014)

Epigenetic regulation of HGF/Met receptor axis is critical for the outgrowth of bone metastasis from breast carcinoma
por: Bendinelli, Paola, et al.
Publicado: (2017)

Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients
por: Palle, Juliette, et al.
Publicado: (2021)

HGF-independent Potentiation of EGFR Action by c-Met
por: Dulak, Austin M., et al.
Publicado: (2011)

The role of HGF/c-MET signaling pathway in lymphoma
por: Lam, Bao Quoc, et al.
Publicado: (2016)

HGF/MET and the Immune System: Relevance for Cancer Immunotherapy
por: Papaccio, Federica, et al.
Publicado: (2018)

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
por: Cruickshanks, Nichola, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g5c7b276188nn26p3fo4m2s41p